Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

by Chan, N., Chan, T., de Meritens, A.B, Ganesan, S., Girda, E., Groisberg, R., Jabbour, S.K, Leiser, A., Malhotra, J., Mayer, T., Mehnert, J., Palmeri, M., Popli, P., Riedlinger, G., Silk, A.W, Spencer, K., Stephenson, R., Subbiah, V.
Published 2022